Insider Trades
Common-stock transactions that officers, directors and 10% owners of healthcare companies report to the SEC on Form 4, from 2006 to today, newest first.
Insider filings are public records and are not a recommendation.
Results
25+ transactions, newest first
| Date | Insider | Relationship | Company | Transaction | Shares | Price | Value | Owned after | Filing |
|---|---|---|---|---|---|---|---|---|---|
| Puri Raj K. | Chief Regulatory Officer | IOVANCE BIOTHERAPEUTICS, INC.IOVA | OtherF · Shares withheld to pay tax or exercise price | 4,478 | $8.70 | $38,958.60 | 256,364Direct | Form 4 filed 10 Sep 2026, on sec.gov (opens in a new tab)Filed 10 Sep 2026 | |
| Puri Raj K. | Chief Regulatory Officer | IOVANCE BIOTHERAPEUTICS, INC.IOVA | OtherM · Option or derivative exercised or converted | 9,766 | $0.00 | $0 | 260,842Direct | Form 4 filed 10 Sep 2026, on sec.gov (opens in a new tab)Filed 10 Sep 2026 | |
| BILINSKY IGOR | Chief Operating Officer | IOVANCE BIOTHERAPEUTICS, INC.IOVA | OtherF · Shares withheld to pay tax or exercise price | 3,976 | $8.70 | $34,591.20 | 142,074Direct | Form 4 filed 10 Sep 2026, on sec.gov (opens in a new tab)Filed 10 Sep 2026 | |
| BILINSKY IGOR | Chief Operating Officer | IOVANCE BIOTHERAPEUTICS, INC.IOVA | OtherM · Option or derivative exercised or converted | 7,813 | $0.00 | $0 | 146,050Direct | Form 4 filed 10 Sep 2026, on sec.gov (opens in a new tab)Filed 10 Sep 2026 | |
| Vogt Frederick G | Director, Interim CEO & General Counsel | IOVANCE BIOTHERAPEUTICS, INC.IOVA | OtherF · Shares withheld to pay tax or exercise price | 6,638 | $8.70 | $57,750.60 | 595,447Direct | Form 4 filed 10 Sep 2026, on sec.gov (opens in a new tab)Filed 10 Sep 2026 | |
| Vogt Frederick G | Director, Interim CEO & General Counsel | IOVANCE BIOTHERAPEUTICS, INC.IOVA | OtherM · Option or derivative exercised or converted | 15,626 | $0.00 | $0 | 602,085Direct | Form 4 filed 10 Sep 2026, on sec.gov (opens in a new tab)Filed 10 Sep 2026 | |
| BILINSKY IGOR | Chief Operating Officer | IOVANCE BIOTHERAPEUTICS, INC.IOVA | OtherF · Shares withheld to pay tax or exercise price | 4,472 | $8.28 | $37,028.16 | 138,237Direct | Form 4 filed 3 Sep 2026, on sec.gov (opens in a new tab)Filed 3 Sep 2026 | |
| BILINSKY IGOR | Chief Operating Officer | IOVANCE BIOTHERAPEUTICS, INC.IOVA | OtherM · Option or derivative exercised or converted | 8,789 | $0.00 | $0 | 142,709Direct | Form 4 filed 3 Sep 2026, on sec.gov (opens in a new tab)Filed 3 Sep 2026 | |
| Puri Raj K. | Chief Regulatory Officer | IOVANCE BIOTHERAPEUTICS, INC.IOVA | OtherF · Shares withheld to pay tax or exercise price | 2,508 | $8.28 | $20,766.24 | 251,076Direct | Form 4 filed 3 Sep 2026, on sec.gov (opens in a new tab)Filed 3 Sep 2026 | |
| Puri Raj K. | Chief Regulatory Officer | IOVANCE BIOTHERAPEUTICS, INC.IOVA | OtherM · Option or derivative exercised or converted | 5,470 | $0.00 | $0 | 253,584Direct | Form 4 filed 3 Sep 2026, on sec.gov (opens in a new tab)Filed 3 Sep 2026 | |
| Vogt Frederick G | Director, Interim CEO & General Counsel | IOVANCE BIOTHERAPEUTICS, INC.IOVA | OtherF · Shares withheld to pay tax or exercise price | 17,702 | $8.28 | $146,572.56 | 586,459Direct | Form 4 filed 3 Sep 2026, on sec.gov (opens in a new tab)Filed 3 Sep 2026 | |
| Vogt Frederick G | Director, Interim CEO & General Counsel | IOVANCE BIOTHERAPEUTICS, INC.IOVA | OtherM · Option or derivative exercised or converted | 41,669 | $0.00 | $0 | 604,161Direct | Form 4 filed 3 Sep 2026, on sec.gov (opens in a new tab)Filed 3 Sep 2026 | |
| Kirby Daniel Gordon | Chief Commercial Officer | IOVANCE BIOTHERAPEUTICS, INC.IOVA | OtherF · Shares withheld to pay tax or exercise price | 2,436 | $6.40 | $15,590.40 | 154,511Direct | Form 4 filed 12 Aug 2026, on sec.gov (opens in a new tab)Filed 12 Aug 2026 | |
| Kirby Daniel Gordon | Chief Commercial Officer | IOVANCE BIOTHERAPEUTICS, INC.IOVA | OtherM · Option or derivative exercised or converted | 10,001 | $0.00 | $0 | 156,947Direct | Form 4 filed 12 Aug 2026, on sec.gov (opens in a new tab)Filed 12 Aug 2026 | |
| Roche Corleen M. | Chief Financial Officer | IOVANCE BIOTHERAPEUTICS, INC.IOVA | OtherF · Shares withheld to pay tax or exercise price | 21,238 | $6.21 | $131,887.98 | 28,757Direct | Form 4 filed 10 Aug 2026, on sec.gov (opens in a new tab)Filed 10 Aug 2026 | |
| Roche Corleen M. | Chief Financial Officer | IOVANCE BIOTHERAPEUTICS, INC.IOVA | OtherM · Option or derivative exercised or converted | 49,995 | $0.00 | $0 | 49,995Direct | Form 4 filed 10 Aug 2026, on sec.gov (opens in a new tab)Filed 10 Aug 2026 | |
| Vogt Frederick G | Director, Interim CEO & General Counsel | IOVANCE BIOTHERAPEUTICS, INC.IOVA | OtherF · Shares withheld to pay tax or exercise price | 6,638 | $4.23 | $28,078.74 | 562,492Direct | Form 4 filed 9 Jun 2026, on sec.gov (opens in a new tab)Filed 9 Jun 2026 | |
| Vogt Frederick G | Director, Interim CEO & General Counsel | IOVANCE BIOTHERAPEUTICS, INC.IOVA | OtherM · Option or derivative exercised or converted | 15,625 | $0.00 | $0 | 569,130Direct | Form 4 filed 9 Jun 2026, on sec.gov (opens in a new tab)Filed 9 Jun 2026 | |
| GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | IOVANCE BIOTHERAPEUTICS, INC.IOVA | OtherF · Shares withheld to pay tax or exercise price | 3,976 | $4.23 | $16,818.48 | 140,111Direct | Form 4 filed 9 Jun 2026, on sec.gov (opens in a new tab)Filed 9 Jun 2026 | |
| GRAF FINCKENSTEIN FRIEDRICH | Chief Medical Officer | IOVANCE BIOTHERAPEUTICS, INC.IOVA | OtherM · Option or derivative exercised or converted | 7,813 | $0.00 | $0 | 144,087Direct | Form 4 filed 9 Jun 2026, on sec.gov (opens in a new tab)Filed 9 Jun 2026 | |
| BILINSKY IGOR | Chief Operating Officer | IOVANCE BIOTHERAPEUTICS, INC.IOVA | OtherF · Shares withheld to pay tax or exercise price | 3,976 | $4.23 | $16,818.48 | 133,920Direct | Form 4 filed 9 Jun 2026, on sec.gov (opens in a new tab)Filed 9 Jun 2026 | |
| BILINSKY IGOR | Chief Operating Officer | IOVANCE BIOTHERAPEUTICS, INC.IOVA | OtherM · Option or derivative exercised or converted | 7,813 | $0.00 | $0 | 137,896Direct | Form 4 filed 9 Jun 2026, on sec.gov (opens in a new tab)Filed 9 Jun 2026 | |
| Puri Raj K. | Chief Regulatory Officer | IOVANCE BIOTHERAPEUTICS, INC.IOVA | OtherF · Shares withheld to pay tax or exercise price | 3,843 | $4.23 | $16,255.89 | 248,114Direct | Form 4 filed 9 Jun 2026, on sec.gov (opens in a new tab)Filed 9 Jun 2026 | |
| Puri Raj K. | Chief Regulatory Officer | IOVANCE BIOTHERAPEUTICS, INC.IOVA | OtherM · Option or derivative exercised or converted | 9,766 | $0.00 | $0 | 251,957Direct | Form 4 filed 9 Jun 2026, on sec.gov (opens in a new tab)Filed 9 Jun 2026 | |
| Puri Raj K. | Chief Regulatory Officer | IOVANCE BIOTHERAPEUTICS, INC.IOVA | OtherF · Shares withheld to pay tax or exercise price | 2,508 | $3.96 | $9,931.68 | 242,191Direct | Form 4 filed 3 Jun 2026, on sec.gov (opens in a new tab)Filed 3 Jun 2026 |
Source: SEC EDGAR Form 4 filings and the SEC Insider Transactions Data Sets (2006 onward). Each row links to its Form 4 filing. Values are shares times the reported price. Nothing here is investment advice.